Indian ER&D firms brace for a bumpy first quarter | TheBriefWire
Indian ER&D firms brace for a bumpy first quarter
Published 9 July 2026 ยท health
Synopsis Among the listed players, Tata Elxsi is expected to report sequential revenue growth of 1.2% in constant currency, helped by demand from the healthcare
Synopsis Among the listed players, Tata Elxsi is expected to report sequential revenue growth of 1.2% in constant currency, helped by demand from the healthcare and media sectors, according to ICICI Securities and Motilal Oswal. Cyient is seen growing up to 1.5%, aided by semiconductor and aerospace traction, while Tata Technologies is expected to report about 1.1% growth.
Published: July 9, 2026 โข 6:00 AM IST ยท Updated: July 9, 2026 โข 8:36 AM ISTBy TheBriefWire Editorial Team
Key points
Synopsis Among the listed players, Tata Elxsi is expected to report sequential revenue growth of 1.2% in constant currency, helped by demand from the healthcare and media sectors, according to ICICI Securities and Motilal Oswal.
Cyient is seen growing up to 1.5%, aided by semiconductor and aerospace traction, while Tata Technologies is expected to report about 1.1% growth.